Intracellular immune checkpoint receptors PD-1/PD-L1 and CTLA-4 signalling and functional effects of their activity and blockage by ICIs in HNSCC are shown in Figure 3A. The gene discussed is CTLA4; the disease is head and neck squamous cell carcinoma.